Use of a Benchmark Tracking Assessment to Support Expansion of Buprenorphine for Treatment of Opioid Use Disorder in Primary Care

References

1. 1.↵
   Centers for Disease Control and Prevention; 2020. Overdose deaths accelerating during COVID-19: expanded efforts needed. Available from: https://www.cdc.gov/media/releases/2020/p1218-overdose-deaths-covid-19.html. Accessed February 25, 2021.
2. 2.↵
   New Mexico Department of Health; 2021. Drug overdose in NM factsheet. Available from: https://www.nmhealth.org/publication/view/marketing/2117/. Accessed May 25, 2021.
3. 3.↵
   1. Mancher M,
   2. Leshner AI

   , editors. Medications for opioid use disorder save lives. Washington (DC): National Academies Press; 2019.
4. 4.↵
   1. Andrilla CHA,
   2. Coulthard C,
   3. Patterson DG

   . Prescribing practices of rural physicians waivered to prescribe buprenorphine. Am J Prev Med 2018;54:S208–S214.

   OpenUrl
5. 5.↵
   1. Ghertner R

   . U.S. trends in the supply of providers with a waiver to prescribe buprenorphine for opioid use disorder in 2016 and 2018. Drug Alcohol Depend 2019;204:107527.

   OpenUrl
6. 6.↵
   1. Andrilla CHA,
   2. Coulthard C,
   3. Larson EH

   . Barriers rural physicians face prescribing buprenorphine for opioid use disorder. Ann Fam Med 2017;15:359–62.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Huhn AS,
   2. Dunn KE

   . Why aren't physicians prescribing more buprenorphine? J Subst Abuse Treat 2017;78:1–7.

   OpenUrlPubMed
8. 8.↵
   1. Hutchinson E,
   2. Catlin M,
   3. Andrilla HA,
   4. Baldwin LM,
   5. Rosenblatt RA

   . Barriers to primary care physicians prescribing buprenorphine. Ann Fam Med 2014;12:128–33.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   Substance Abuse and Mental Health Services Administration; 2021. Become a buprenorphine waivered practitioner. Available from: https://www.samhsa.gov/medication-assisted-treatment/become-buprenorphine-waivered-practitioner. Accessed May 28, 2021.
10. 10.↵
    1. Salvador J,
    2. Bhatt S,
    3. Fowler R,
    4. et al

    . Engagement with project ECHO to increase medication-assisted treatment in rural primary care. Psychiatr Serv 2019;70:1157–60.

    OpenUrlPubMed
11. 11.↵
    1. Salvador JG,
    2. Bhatt SR,
    3. Jacobsohn VC,
    4. et al

    . Feasibility and acceptability of an online ECHO intervention to expand access to medications for treatment of opioid use disorder, psychosocial treatments and supports. Subst Abus 2020;19:1–8.

    OpenUrl
12. 12.↵
    1. Berk J

    . To help providers fight the opioid epidemic, “x the X waiver.” Health Affairs; 2019. Available from: https://www.healthaffairs.org/do/10.1377/hblog20190301.79453/full/. Accessed February 25, 2021.
13. 13.↵
    1. Frank JW,
    2. Wakeman SE,
    3. Gordon AJ

    . No end to the crisis without an end to the waiver. Subst Abus 2018;39:263–5.

    OpenUrl
14. 14.↵
    1. Zinsmaster DS,
    2. Begin CB

    . X-waiver changes axed: federal government backtracks on previously announced rescission of waiver requirements. National Law Review; 2021. Available from: https://www.natlawreview.com/article/x-waiver-changes-axed-federal-government-backtracks-previously-announced-rescission. Accessed February 25, 2021.